According to the Digest`s Editorial office opinion, the main events of the June 2023 in Russian pharmaceutical industry are:
- Russia has approved a strategy for the pharmaceutical industry development until 2030. In the next eight years, the share of domestic full-cycle medicines on the Russian market should be increased up to almost 70%;
- the Moscow veterinary drugs manufacturer received a GMP-certificate and entered the Turkish market;
- The Ministry of Health has developed a new requirements version for off-label medicines;
- experts: Russia may lose 94% of imported veterinary drugs after September 1;
- the regulator rejected seven batches of substandard medicines.
These, as well all other industry month news, are in the June 2023 issue (Russian edition) of the Digest.
Best regards,
Natalia Egorova, Editor-in-Chief
01.07.2023.